Eastman (NYSE:EMN) today announced it has secured a significant amount of feedstock needed for its planned molecular recycling facility in Port Jerome sur Seine, Normandy, France. With an investment
- CYB003 capsule formulation is designed to be stable, dose flexible, patient-friendly and commercially scalable -
- Shipments of CYB003 capsules to clinical sites expected in Q1 2024 -
- Recently granted